Northern New Jersey Hospitals Collaborate to Defeat Healthcare-Acquired Infections

Article

The Valley Hospital in Ridgewood, N.J., and Holy Name Medical Center in Teaneck, N.J., are collaborating to defeat Clostridium difficile. The two hospitals recently announced the formation of the Valley-Holy Name Joint Healthcare-Acquired Infections/Antibiotic Resistance Collaborative.

C. difficile is a bacterium that can cause symptoms ranging from diarrhea to life-threatening inflammation of the colon. It was responsible for almost half a million infections and was associated with approximately 29,000 deaths in 2011, according to a study released last year by the Centers for Disease Control and Prevention (CDC).

“C. difficile is public enemy No. 1 and it is clear that defeating it will take a cooperative, multi-institutional and multidisciplinary approach, since the infection can be picked up at any point in a patient’s care and can be transmitted from institution to institution," says Neil Gaffin, MD, an infectious disease specialist at The Valley Hospital, “No one is going to get anywhere without working together.”

The CDC study found that 65.8 percent of the cases of C. difficile were healthcare-associated, but only 24.2 percent had onset during hospitalization. The rest originated in a nursing home or were associated with having received outpatient care at a healthcare facility. The CDC has called upon healthcare facilities to work together to fight C. difficile, noting that because these infections can be spread inside of and between healthcare facilities when patients are transferred from one facility to another, a lack of coordination can put patients at risk.

Healthcare organizations are working very hard to meet the challenge of this organism, which is resistant to antibiotics causing overgrowth in the intestine in patients who are receiving antibiotic and produces a spore which persists in the environment, unaffected by soap and water as well as alcohol-based sanitizers. In addition, this organism produces a toxin which causes disease.

“We are employing bleach–based disinfectants, which are the only compounds that will inactivate the spores, and are restricting the use, spectrum and duration of antibiotic therapy to preserve the normal organisms in a patient,” says Thomas Birch, MD, an infectious disease specialist at Holy Name Medical Center.

Valley has also instituted an aggressive campaign to reduce the unnecessary use of antibiotics and a comprehensive environmental disinfection program.

The Valley Hospital and Holy Name Medical Center are following the CDC’s recommendation and taking a collaborative approach to the problem. Representative of both hospitals are meeting regularly to share best practices - including restricting the use of antibiotics, infection control practices and procedures, and diagnosis and treatment protocols - and are working with area nursing homes in an effort to limit the spread of C. difficile throughout the healthcare continuum.

Source: Valley Health System 

 

Related Videos
Andrea Flinchum, 2024 president of the Certification Board of Infection Control and Epidemiology, Inc (CBIC) explains the AL-CIP Certification at APIC24
Association for Professionals in Infection Control and Epidemiology  (Image credit: APIC)
Lila Price, CRCST, CER, CHL, the interim manager for HealthTrust Workforce Solutions; and Dannie O. Smith III, BSc, CSPDT, CRCST, CHL, CIS, CER, founder of Surgicaltrey, LLC, and a central processing educator for Valley Health System
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Related Content